Consensus Report From the Miami Liver Proton Therapy Conference.
cholangiocarcinoma (CC)
hepatocellular carcinoma (HCC)
liver cancer
liver metastases
proton therapy
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
10
04
2019
accepted:
14
05
2019
entrez:
20
6
2019
pubmed:
20
6
2019
medline:
20
6
2019
Statut:
epublish
Résumé
An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.
Identifiants
pubmed: 31214502
doi: 10.3389/fonc.2019.00457
pmc: PMC6557299
doi:
Types de publication
Journal Article
Langues
eng
Pagination
457Références
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S94-100
pubmed: 20171524
J Clin Oncol. 2013 May 1;31(13):1631-9
pubmed: 23547075
Radiother Oncol. 2014 Jun;111(3):412-7
pubmed: 24906626
Pract Radiat Oncol. 2015 Jul-Aug;5(4):209-18
pubmed: 25703530
J Clin Oncol. 2016 Jan 20;34(3):219-26
pubmed: 26503201
J Clin Oncol. 2016 Feb 10;34(5):460-8
pubmed: 26668346
Cancer Sci. 2017 Mar;108(3):497-503
pubmed: 28012214
Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):939-946
pubmed: 28333016
JAMA Oncol. 2018 Jan 1;4(1):40-47
pubmed: 28796864
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28954285
Int J Radiat Oncol Biol Phys. 2018 Jan 6;:
pubmed: 29395629
Semin Radiat Oncol. 2018 Oct;28(4):309-320
pubmed: 30309641